Français

Symposium on Access to Cell and Gene Therapies
Hosted by Advancing Cell and Gene Therapy in partnership with Life Sciences Ontario

Join us for an engaging and solutions-focused event bringing together key voices from across the healthcare ecosystem—including patient advocates, clinicians, researchers, hospital administrators, industry leaders, and government representatives—to tackle one of the most pressing issues in Canadian healthcare: ensuring equitable access to cell and gene therapies.

The Symposium on Access to Cell and Gene Therapies will be an interactive forum designed to generate actionable recommendations that help realize the full potential of these transformative treatments for all Canadians. As a leader committed to improving healthcare outcomes, your voice and insights are invaluable to this conversation.

Date: Thursday, October 30, 2025

Time:

  • 8:30 AM - 9:00 AM - Registration and Networking
  • 9:00 AM - 12:00 PM - Program

Venue: MaRS Discovery District, 101 College St., Toronto ON

 

About Advancing Cell & Gene Therapy
Established in 2022, Advancing Cell & Gene Therapy is a coalition of leading pharmaceutical innovators—including Alexion, Johnson & Johnson Innovative Medicines, Novo Nordisk, Ultragenyx, Vertex Pharmaceuticals, Pfizer, and Ferring Pharmaceuticals—working collaboratively to advance equitable access to life-changing and lifesaving therapies across Canada.

We invite you to be part of shaping the future of healthcare innovation.

For questions on the program, please reach out to Sarah Kabani at Sarah.Kabani@bursonglobal.com

Advancing Cell and Gene Therapy Symposium

Register Now

  • Thursday Oct 30 2025, 8:30 AM - 12:00 PM
  • MaRS Discovery District, 101 College Street
    Toronto, Ontario
    Canada
    M5G 0A3